127 related articles for article (PubMed ID: 35992245)
1. Comparing Survival in Patients With Lung Cancer With and Without a History of Common Autoimmune Disease.
Dedousis D; Vassiliou AN; Cao S; Yammani D; Kyasaram RK; Shanahan J; Keinath MC; Zhang AL; Hsu ML; Fu P; Dowlati A
JTO Clin Res Rep; 2022 Sep; 3(9):100375. PubMed ID: 35992245
[TBL] [Abstract][Full Text] [Related]
2. Survival in elderly patients with breast cancer with and without autoimmune disease.
Dedousis D; Zhang AL; Vassiliou AN; Cao S; Yammani D; Kyasaram RK; Shanahan JP; Keinath MC; Hsu ML; Fu P; Dowlati A; Montero AJ
Cancer Med; 2023 Jun; 12(12):13086-13099. PubMed ID: 37102221
[TBL] [Abstract][Full Text] [Related]
3. Comparison of cisplatin/etoposide versus carboplatin/etoposide concurrent chemoradiation therapy for limited-stage small cell lung cancer (LS-SCLC) in the elderly population (age >65 years) using national SEER-Medicare data.
Kim E; Biswas T; Bakaki P; Dowlati A; Sharma N; Machtay M
Pract Radiat Oncol; 2016; 6(5):e163-e169. PubMed ID: 27142494
[TBL] [Abstract][Full Text] [Related]
4. Cardiac mortality in limited-stage small cell lung cancer.
Verma V; Fakhreddine MH; Haque W; Butler EB; Teh BS; Simone CB
Radiother Oncol; 2018 Sep; 128(3):492-497. PubMed ID: 29934110
[TBL] [Abstract][Full Text] [Related]
5. Surgery Plus Chemotherapy Versus Surgery Alone for Limited-Stage Small-Cell Lung Cancer: A Population-Based Survival Outcome Analysis.
Ye P; Guo Z; Zhang Y; Dong C; Li M
Front Oncol; 2021; 11():676598. PubMed ID: 34079765
[TBL] [Abstract][Full Text] [Related]
6. Surgery for small cell lung cancer: A Surveillance, Epidemiology, and End Results (SEER) Survey from 2010 to 2015.
Xu L; Zhang G; Song S; Zheng Z
Medicine (Baltimore); 2019 Oct; 98(40):e17214. PubMed ID: 31577711
[TBL] [Abstract][Full Text] [Related]
7. Second Primary Non-Small-Cell Lung Cancer After Head and Neck Cancer: A Population-Based Study of Clinical and Pathologic Characteristics and Survival Outcomes in 3597 Patients.
Budnik J; DeNunzio NJ; Singh DP; Milano MT
Clin Lung Cancer; 2020 May; 21(3):195-203. PubMed ID: 30914310
[TBL] [Abstract][Full Text] [Related]
8. Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study.
Miret M; Horváth-Puhó E; Déruaz-Luyet A; Sørensen HT; Ehrenstein V
PLoS One; 2017; 12(8):e0181564. PubMed ID: 28767671
[TBL] [Abstract][Full Text] [Related]
9. Real-World Outcomes and Clinical Predictors of Immune Checkpoint Inhibitor Monotherapy in Advanced Lung Cancer.
Zhang S; Pease DF; Kulkarni AA; Kumar M; Shanley RM; Xu B; Joshi SP; Patel MR
Clin Med Insights Oncol; 2021; 15():11795549211004489. PubMed ID: 34248362
[TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes for Patients with Surgical and Non-Surgical Treatments in Stages I-III Small-Cell Lung Cancer.
Che K; Shen H; Qu X; Pang Z; Jiang Y; Liu S; Yang X; Du J
J Cancer; 2018; 9(8):1421-1429. PubMed ID: 29721052
[No Abstract] [Full Text] [Related]
11. Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database.
Yang L; Zhou Y; Wang G; Liu D; Chen B; Pu D; Correale P; Rades D; Tomita Y; Inno A; Santarpia M; Li Y; Li W
Transl Lung Cancer Res; 2021 Nov; 10(11):4250-4265. PubMed ID: 35004254
[TBL] [Abstract][Full Text] [Related]
12. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
13. Lung Cancer Survival in Patients With Autoimmune Disease.
Jacob S; Rahbari K; Tegtmeyer K; Zhao J; Tran S; Helenowski I; Zhang H; Walunas T; Varga J; Dematte J; Villaflor V
JAMA Netw Open; 2020 Dec; 3(12):e2029917. PubMed ID: 33315114
[TBL] [Abstract][Full Text] [Related]
14. Large-Cell Neuroendocrine Carcinoma of the Lung: A Population-Based Study.
Kinslow CJ; May MS; Saqi A; Shu CA; Chaudhary KR; Wang TJC; Cheng SK
Clin Lung Cancer; 2020 Mar; 21(2):e99-e113. PubMed ID: 31601526
[TBL] [Abstract][Full Text] [Related]
15. Effect of surgery on survival in patients with stage III N2 small cell lung cancer: propensity score matching analysis and nomogram development and validation.
Chai Y; Ma Y; Feng W; Lu H; Jin L
World J Surg Oncol; 2021 Aug; 19(1):258. PubMed ID: 34461929
[TBL] [Abstract][Full Text] [Related]
16. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
[No Abstract] [Full Text] [Related]
17. The utility of histological subtype for predicting survival of lung cancer patients with rheumatoid arthritis.
Park DW; Choi J; Chung SJ; Park TS; Lee H; Moon JY; Kim SH; Kim TH; Yoon HJ; Sohn JW
Transl Cancer Res; 2020 Apr; 9(4):2627-2637. PubMed ID: 35117622
[TBL] [Abstract][Full Text] [Related]
18. Propensity score matched analysis for the role of surgery in stage Ⅲ small cell lung cancer based on the eighth edition of the TNM classification: a population study of the US SEER database and a Chinese hospital.
Gao L; Shen L; Wang K; Lu S
Lung Cancer; 2021 Dec; 162():54-60. PubMed ID: 34739854
[TBL] [Abstract][Full Text] [Related]
19. The prognostic value of lymph node ratio in patients with surgically resected stage I-III small-cell lung cancer: a propensity score matching analysis of the SEER database.
Yang H; Mei T
Eur J Cardiothorac Surg; 2021 Nov; 60(5):1212-1220. PubMed ID: 34195790
[TBL] [Abstract][Full Text] [Related]
20. Second malignancy in non-small cell lung cancer (NSCLC): prevalence and overall survival (OS) in routine clinical practice.
Faehling M; Schwenk B; Kramberg S; Fallscheer S; Leschke M; Sträter J; Eckert R
J Cancer Res Clin Oncol; 2018 Oct; 144(10):2059-2066. PubMed ID: 30062488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]